Proteomic Profiling to Reveal Novel Prognostic Markers for Neurological Outcome Following Resuscitation
1 other identifier
observational
96
1 country
1
Brief Summary
Background: Cardiac arrest is a life-threatening event. Intensivists are challenged with an increasing number of patients with uncertain neurological outcome following cardiopulmonary resuscitation (CPR). The prognostic value of current biomarkers for neurophysiologic long-term outcome is limited. Hypothesis: We hypothesize that specific brain-derived tissue leakage proteins can be identified to reveal novel, more reliable prognostic biomarkers for good neurological outcome. Methods: This translational study (n=100) is a combination of a prospective basic science study intended to reduce the number of potential plasma biomarker candidates by proteomic shotgun analyses in brain tissue autopsy samples and plasma samples from resuscitated patients (n=10) and a prospective clinical validation study in a large study population (n=90) by high-throughput analyses. Selection of proteomic markers and signature estimation will be performed to discriminate patients with good and poor outcome. Clinical perspective: A structured proteomic analysis approach might identify the best marker out of all proteins liberated during cellular damage.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2013
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2013
CompletedFirst Submitted
Initial submission to the registry
October 8, 2013
CompletedFirst Posted
Study publicly available on registry
October 11, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2020
CompletedFebruary 24, 2020
February 1, 2020
6.3 years
October 8, 2013
February 20, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Cerebral performance categories (CPC)of <3
participants will be followed for the duration of intensive-care unit stay, an expected average of 2 weeks.
Secondary Outcomes (1)
Cerebral performance categories (CPC)of <3
6 Months
Other Outcomes (2)
Brain glucose metabolism
Day 1 after end of cooling period
Clinical outcome (rehospitalization and death)
3 years
Study Arms (2)
CPC < 3
Good neurological outcome
CPC >/= 3
Unvavourable neurologic outcome
Eligibility Criteria
Resuscitated patients
You may qualify if:
- Nontraumatic, normothermic cardiac arrest due to cardiac disorders, respiratory failures, or hemodynamic or metabolic factors.
- A Glasgow Coma Scale of 3, none of the patients will be conscious at the time of hospital admission.
- No previous cardiac arrest, as well as known or coexisting neurological disorders or neoplasms of the central nervous system.
- No history of psychiatric illness, no alcohol or drug dependency, and no psychotropic medication.
- Initiation of mild therapeutic hypothermia
You may not qualify if:
- hydrocephalus and shunt artifact
- severe movement artifacts
- intracerebral hemorrhage
- old large ischemic lesion
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Medical University of Vienna
Vienna, 1090, Austria
Related Publications (1)
Distelmaier K, Muqaku B, Wurm R, Arfsten H, Seidel S, Kovacs GG, Mayer RL, Szekeres T, Wallisch C, Hubner P, Goliasch G, Heinze G, Heinz G, Sterz F, Gerner C, Adlbrecht C. Proteomics-Enriched Prediction Model for Poor Neurologic Outcome in Cardiac Arrest Survivors. Crit Care Med. 2020 Feb;48(2):167-175. doi: 10.1097/CCM.0000000000004105.
PMID: 31939784RESULT
Biospecimen
Plasma samples stored at -80°C
Study Officials
- PRINCIPAL INVESTIGATOR
Christopher Adlbrecht, MD
Medical University of Vienna
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 3 Years
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PI
Study Record Dates
First Submitted
October 8, 2013
First Posted
October 11, 2013
Study Start
October 1, 2013
Primary Completion
January 1, 2020
Study Completion
January 1, 2020
Last Updated
February 24, 2020
Record last verified: 2020-02